A study released Friday found that kid-size doses of Pfizer’s Covid vaccine are nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds.
Related Articles
-
Global vaccine rollout meets division, delay and disarray
The global rollout of coronavirus vaccines was never going to be easy. But it quickly descended into frustration at...
-
WHO team arrives in Wuhan to investigate pandemic origins
WUHAN, China — A global team of researchers arrived Thursday in the Chinese city where the coronavirus was first...
-
Co-infection reported in California: Flu and Covid
A person has tested positive for both the flu and the coronavirus in Solano County, California, the county health...
-
How the Dobbs abortion ruling is reshaping adoption
Madelynn Ballenger discovered she was pregnant for the second time at 20 years old. Already a single mother to...
-
What decongestants work? Here are some alternatives to phenylephrine.
Walk down the cold and flu aisle in any drugstore and you’ll spot dozens of over-the-counter drugs that contain...
-
Covid-19 vaccine researchers left in the dark as trials remain on hold
In early September, 37 volunteers received their first dose of AstraZeneca’s Covid-19 vaccine candidate at University Hospital at the...
-
Black people have the highest rates of death from heart disease. Could more Black cardiologists help?
For Elston Harris, heart attacks seem to be a generational curse. Several men from his father’s side of the...
-
Majority of mumps cases are among the vaccinated, CDC finds
Mumps cases continue to circulate in the U.S., largely among vaccinated people, including children. Cases of mumps, once a...
Recent Comments